Benjamin F. Edwards & Company’s Colgate-Palmolive CL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
$10.1M Buy
104,427
+6,554
+7% +$605K 0.18% 145
2024
Q1
$8.81M Buy
97,873
+1,737
+2% +$147K 0.16% 150
2023
Q4
$7.66M Buy
96,136
+85,346
+791% +$6.42M 0.15% 155
2023
Q3
$767K Sell
10,790
-64
-0.6% -$4.79K 0.03% 434
2023
Q2
$836K Sell
10,854
-664
-6% -$51.4K 0.03% 408
2023
Q1
$866K Sell
11,518
-169
-1% -$12.6K 0.04% 366
2022
Q4
$921K Sell
11,687
-558
-5% -$41.8K 0.04% 344
2022
Q3
$860K Sell
12,245
-693
-5% -$54.3K 0.04% 331
2022
Q2
$1.04M Buy
12,938
+1,007
+8% +$78.7K 0.05% 316
2022
Q1
$905K Buy
11,931
+2,855
+31% +$226K 0.04% 359
2021
Q4
$775K Buy
9,076
+58
+0.6% +$4.53K 0.03% 391
2021
Q3
$682K Sell
9,018
-254
-3% -$20.2K 0.03% 406
2021
Q2
$754K Sell
9,272
-3,126
-25% -$256K 0.04% 380
2021
Q1
$977K Buy
12,398
+287
+2% +$22.5K 0.05% 337
2020
Q4
$1.04M Buy
12,111
+2,495
+26% +$206K 0.06% 293
2020
Q3
$742K Buy
9,616
+765
+9% +$58.3K 0.05% 326
2020
Q2
$648K Sell
8,851
-1,473
-14% -$105K 0.05% 327
2020
Q1
$685K Sell
10,324
-2,153
-17% -$152K 0.06% 289
2019
Q4
$859K Sell
12,477
-155
-1% -$10.6K 0.06% 296
2019
Q3
$929K Buy
12,632
+3,173
+34% +$230K 0.07% 270
2019
Q2
$678K Sell
9,459
-130
-1% -$9.23K 0.06% 303
2019
Q1
$657K Buy
9,589
+563
+6% +$36.4K 0.06% 291
2018
Q4
$537K Buy
9,026
+2,863
+46% +$179K 0.06% 293
2018
Q3
$413K Buy
6,163
+136
+2% +$9.06K 0.04% 361
2018
Q2
$391K Buy
6,027
+519
+9% +$33.9K 0.04% 369
2018
Q1
$395K Sell
5,508
-10,011
-65% -$720K 0.04% 362
2017
Q4
$1.17M Buy
15,519
+1,615
+12% +$118K 0.12% 181
2017
Q3
$1.01M Buy
13,904
+1,764
+15% +$127K 0.12% 172
2017
Q2
$900K Sell
12,140
-602
-5% -$44.7K 0.12% 180
2017
Q1
$933K Buy
12,742
+698
+6% +$48.9K 0.14% 166
2016
Q4
$788K Buy
12,044
+705
+6% +$48.3K 0.13% 173
2016
Q3
$841K Sell
11,339
-4
-0% -$296 0.15% 151
2016
Q2
$830K Sell
11,343
-1,426
-11% -$102K 0.16% 143
2016
Q1
$902K Buy
12,769
+341
+3% +$22.7K 0.19% 122
2015
Q4
$828K Sell
12,428
-203
-2% -$13.5K 0.18% 127
2015
Q3
$802K Buy
12,631
+1,154
+10% +$75.4K 0.18% 125
2015
Q2
$751K Sell
11,477
-1,832
-14% -$124K 0.15% 146
2015
Q1
$923K Buy
13,309
+2,370
+22% +$164K 0.19% 115
2014
Q4
$757K Buy
10,939
+602
+6% +$40.7K 0.18% 133
2014
Q3
$674K Buy
10,337
+1,410
+16% +$93K 0.17% 144
2014
Q2
$609K Buy
8,927
+81
+0.9% +$5.43K 0.15% 153
2014
Q1
$574K Buy
8,846
+2,922
+49% +$184K 0.16% 150
2013
Q4
$386K Buy
5,924
+129
+2% +$8.26K 0.13% 174
2013
Q3
$344K Buy
5,795
+915
+19% +$54.2K 0.13% 170
2013
Q2
$280K Buy
+4,880
New +$290K 0.11% 174

Other funds holding CL

Benjamin F. Edwards & Company's CL Position: Q2 2024 in Review

Benjamin F. Edwards & Company increased its Colgate-Palmolive (CL) stake by 6.7% in Q2 2024, buying an estimated $605K and bringing the position to 104,427 shares worth $10.1M. The position accounts for 0.18% of the portfolio, ranked #145.

Benjamin F. Edwards & Company first reported a position in CL in Q2 2013 and has held it in 45 quarters since. 1,820 funds tracked by Wall St. Rank hold CL as of Q2 2024.

  • Benjamin F. Edwards & Company held 104,427 shares of Colgate-Palmolive worth $10.1M as of Q2 2024.
  • Benjamin F. Edwards & Company bought 6,554 Colgate-Palmolive shares in Q2 2024, an estimated $605K.
  • Colgate-Palmolive made up 0.18% of Benjamin F. Edwards & Company's portfolio in Q2 2024, its #145 holding.
  • Benjamin F. Edwards & Company first reported a position in Colgate-Palmolive in Q2 2013 and has held it in 45 quarters since.
  • 1,820 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q2 2024.

Based on Benjamin F. Edwards & Company's 13F filing for Q2 2024, filed 12 Aug 2024.